Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Verve Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- +26 vs. Q4 2024
- Shares held
- 80.8M
- +3.42M (+4.4%) vs. Q4 2024
- Total value
- $369.3M
- −$67.1M (−15.4%) vs. Q4 2024
- New holders
- 42
- 54 more added
- Sold out
- 16
- 64 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,339−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −12,466−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −11,468−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −11,411−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,810−100.0% | Sold out |
| Creekmur Asset Management LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |